Literature DB >> 17486172

Association of insulin sensitivity and muscle strength in overweight and obese sedentary postmenopausal women.

Antony D Karelis1, Benoit Tousignant, Julie Nantel, Majorique Proteau-Labelle, Florin M Malita, David H St-Pierre, Martin Brochu, Eric Doucet, Rémi Rabasa-Lhoret.   

Abstract

The objective of this study was to examine the relationship between insulin sensitivity and lower body muscle strength in overweight and obese sedentary postmenopausal women. The design of the study was cross-sectional. The study population consisted of 82 non-diabetic overweight and obese sedentary postmenopausal women (age: 58.2 +/- 5.1 y; body mass index (BMI): 32.4 +/- 4.6 kg.m-2). Subjects were classified by dividing the entire cohort into quartiles based on relative insulin sensitivity expressed per kilograms of lean body mass (LBM) (Q1, < 10.3, vs. Q2, 10.3-12.4, vs. Q3, 12.5-14.0, vs. Q4, >14.0 mg.min-1.kg LBM-1). We measured insulin sensitivity (using the hyperinsulinemic-euglycemic clamp technique), body composition (using dual-energy X-ray absorptiometry), visceral fat and muscle attenuation (using computed tomography), and a lower-body muscle strength index expressed as weight lifted in kilograms per kilogram of LBM (kg.kg LBM-1) (using weight-training equipment). A positive and significant relationship was observed between insulin sensitivity and the muscle strength index (r = 0.37; p < 0.001). Moreover, a moderate but significant correlation was observed between the muscle strength index and muscle attenuation (r = 0.22; p < 0.05). Finally, the muscle strength index was significantly higher in the Q4 group compared with the Q2 and Q1 groups, respectively (3.78 +/- 1.13 vs. 2.99 +/- 0.77 and 2.93 +/- 0.91 kg.kg LBM-1; p < 0.05). Insulin sensitivity is positively associated with lower-body muscle strength in overweight and obese sedentary postmenopausal women.

Entities:  

Mesh:

Year:  2007        PMID: 17486172     DOI: 10.1139/H07-002

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  6 in total

1.  Dynapenia and Metabolic Health in Obese and Nonobese Adults Aged 70 Years and Older: The LIFE Study.

Authors:  Mylène Aubertin-Leheudre; Stephen Anton; Daniel P Beavers; Todd M Manini; Roger Fielding; Ann Newman; Tim Church; Stephen B Kritchevsky; David Conroy; Mary M McDermott; Anda Botoseneanu; Michelle E Hauser; Marco Pahor
Journal:  J Am Med Dir Assoc       Date:  2016-11-30       Impact factor: 4.669

2.  Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.

Authors:  Daniel Cabrera; Alex Ruiz; Claudio Cabello-Verrugio; Enrique Brandan; Lisbell Estrada; Margarita Pizarro; Nancy Solis; Javiera Torres; Francisco Barrera; Marco Arrese
Journal:  Dig Dis Sci       Date:  2016-08-29       Impact factor: 3.199

3.  Relationships between insulin sensitivity, skeletal muscle mass and muscle quality in obese adolescent boys.

Authors:  S Lee; Y Kim; D A White; J L Kuk; S Arslanian
Journal:  Eur J Clin Nutr       Date:  2012-10-17       Impact factor: 4.016

4.  Physical functioning related to C-reactive protein and fibrinogen levels in mid-life women.

Authors:  Kristin Tomey; MaryFran Sowers; Huiyong Zheng; Elizabeth A Jackson
Journal:  Exp Gerontol       Date:  2009-10-09       Impact factor: 4.032

5.  Prediction of Cardiorespiratory Fitness by the Six-Minute Step Test and Its Association with Muscle Strength and Power in Sedentary Obese and Lean Young Women: A Cross-Sectional Study.

Authors:  Lívia Pinheiro Carvalho; Luciana Di Thommazo-Luporini; Mylène Aubertin-Leheudre; José Carlos Bonjorno Junior; Cláudio Ricardo de Oliveira; Rafael Luís Luporini; Renata Gonçalves Mendes; Katiany Thais Lopes Zangrando; Renata Trimer; Ross Arena; Audrey Borghi-Silva
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

6.  Dynapenic Obesity and Prevalence of Type 2 Diabetes in Middle-Aged Japanese Men.

Authors:  Ryoko Kawakami; Susumu S Sawada; I-Min Lee; Munehiro Matsushita; Yuko Gando; Takashi Okamoto; Koji Tsukamoto; Mitsuru Higuchi; Motohiko Miyachi; Steven N Blair
Journal:  J Epidemiol       Date:  2015-08-08       Impact factor: 3.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.